Preview Mode Links will not work in preview mode

This Week in Cardiology

Mar 3, 2023

Renal denervation, AF ablation, omecamtiv mecarbil, and an ACC Preview are the topics discussed by John Mandrola, MD, in this week’s podcast.

This podcast is intended for healthcare professionals only.

To read a partial transcript or to comment, visit:

I. AF Ablation

- Initial Findings From the National Cardiovascular Data Registry of Atrial Fibrillation Ablation Procedures

II. Renal Denervation

Consistent BP Cut With Renal Denervation: More on RADIANCE

- Endovascular Ultrasound Renal Denervation to Treat HypertensionThe RADIANCE II Randomized Clinical Trial

- Patient-Level Pooled Analysis of Ultrasound Renal Denervation in the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO Trials

- Is There a Role for Renal Denervation in the Treatment of Hypertension?

III. Omecamtiv Mecarbil

FDA Declines Approval for Omecamtiv Mecarbil in HFrEF

IV. ACC Preview

ACC Scientific Session Returns Live, Virtually to New Orleans

- ‘Faith Healing’ and ‘Subtraction Anxiety’ in Unblinded Trials of Procedures


Mandrola's 5 Things to Look for at ACC 23

You may also like:

Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine

The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD.

Questions or feedback, please contact